ethics and medical research
DESCRIPTION
Ethics and Medical Research. Richard L. Elliott, MD, PhD Professor and Director, M edical Ethics Mercer University School of Medicine. Ethics and Research. Who has done research? Published? When do you think are some ethical issues in research - PowerPoint PPT PresentationTRANSCRIPT
Ethics and Medical Research
Richard L. Elliott, MD, PhDProfessor and Director, Medical EthicsMercer University School of Medicine
Ethics and Research
• Who has done research? Published?• When do you think are some ethical
issues in research• Have you encountered ethical issues in
research?
A few questions about ethics in research
• Lack of informed consent – Do patients-subjects know what they are consenting to?
• Mistreatment of subjects – Are subjects being treated fairly, not being abused?
• Falsification of data – Is evidence-based medicine reliable?
• Conflicts of interest – Is unfavorable data suppressed?
• Authorship – Do we really know who is responsible for conducting a study?
Prevalence of scientific misconduct: Fanelli2% scientists admit to serious misconduct – fabrication, falsification, plagiarism34% admit to questionable practices – dropping data points, changing research design to get favorable results
Studying Scientific Misconduct
• International Committee of Medical Journal Editors• Emanuel et al. What makes clinical research ethical?• Data falsification and fabrication• Fall 2012 - The Integrity of Evidence-Based Medicine
– History of ethics in medical research• Tuskegee
– Institutional Review Boards– Medical industry, medical research, and medical
education
ICMJE
• International Committee of Medical Journal Editors– JAMA, NEJM, Lancet, BMJ, many others– http://www.icmje.org/– Authorship, contributorship, and editorship– Peer review– Conflicts of interest– Privacy and confidentiality– Protection of human subjects and animals in research– Obligation to publish negative findings– Overlapping publications
ICMJE - Authorship
• Author means having made substantial intellectual contribution
• Design, data acquisition, and/or analysis• Draft or revision of article, final approval • Each author should be able to take public
responsibility for the work
Ghost authors and “Guest” authors
• Wislar et al. – 896 Corresponding authors published in JAMA, NEJM, Lancet,
PLoS Medicine, Ann Int Med, Nature Medicine• Ghost authorship 11.0% in original research articles• Honorary authorship 25% in original research articles• 21% articles with inappropriate authorship
• Gotzsche et al. PLoS Medicine– http://www.plosmedicine.org/article/info:doi/10.1371/
journal.pmed.0040019 – 75% industry sponsored trial with ghost authors (stats mostly)
• Major textbook of psychiatry ghost authored• Use of Prempro, HRT based on ghost authored paper• Vioxx studies by Merck used honorary and ghost authors
ICMJE – Peer review
• Peer review process not specified by ICMJE• Purpose: to provide fair, disinterested input on
quality of article submitted– Blinded review (identity of author(s) removed)– Random selection of qualified reviewers– Reviewers disclose conflicts of interest– Having a peer read a paper is not peer review– Reviewers paper’s contents
Concerns with peer review
• Not truly blinded• Misuse of information learned during peer
review• Peer review may be biased against
revolutionary ideas
ICMJE – Conflicts of interest
• Freedom from financial or personal interests that create bias– Disclosure vs meaningful disclosure of
financial interests– Other interests: personal relationships,
academic competition, bias about value of work
• Editorial Conflicts of interest– Revenue from advertisers
ICMJE – Privacy and confidentiality
• Protect identity of subjects, patients– Remove identifying information or disguise
• Patient in her 40s vs 46 year old– Informed consent if potentially identifiable
• Author and reviewer confidentiality should be protected
ICMJE – Protection of human subjects
• Paper should state whether study was carried out according to Helsinki Declaration
• IRB approval • Protection of animal subjects
ICMJE – Negative studies
• Publication bias – failure to publish negative trials– Undermines meta-analytic studies of efficacy
• Antidepressants• Many journals require studies to have
been registered with clinicaltrials.gov
ICMJE – Duplicate submissions
• Submit to one journal only• If there are conflicting or competing
publications from the same study, the journal editor should be informed
Emanuel - JAMA
• Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701-2711– Social or scientific value– Scientific validity– Fair subject selection– Favorable risk-benefit ratio– Independent review– Informed consent– Respect for potential and enrolled subjects
• Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701-2711– Social or scientific value– Are the right questions being asked?
• Avoid “trivial pursuits” - LPUs• Resource allocation• Non-maleficence (risks should be justified by possible benefits)
– MCG psychotherapy study
– Scientific validity– Fair subject selection– Favorable risk-benefit ratio– Independent review– Informed consent– Respect for potential and enrolled subjects
• Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701-2711– Social or scientific value– Scientific validity
• Is study carried out properly? Do researchers posses necessary expertise?• Invalid studies – clinical trials against improperly dosed comparison drug• VA study of psychosocial therapies with poorly defined interventions
– What was meant by psychoeducation? Rehabilitation?
– Fair subject selection– Favorable risk-benefit ratio– Independent review– Informed consent– Respect for potential and enrolled subjects
• Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701-2711– Social or scientific value– Scientific validity– Fair subject selection
• Subject recruitment should meet scientific needs• Groups exposed to risks should share in benefits• Not biased by socioeconomic or other factors
– Tuskegee
– Favorable risk-benefit ratio– Independent review– Informed consent– Respect for potential and enrolled subjects
• Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701-2711– Social or scientific value– Scientific validity– Fair subject selection– Favorable risk-benefit ratio
• Potential risks are minimized, potential benefits enhanced• Potential benefits are proportional to or exceed potential risks• Phase I trials?
– Independent review– Informed consent– Respect for potential and enrolled subjects
• Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701-2711– Social or scientific value– Scientific validity– Fair subject selection– Favorable risk-benefit ratio– Independent review
• Review by a party with no stake in outcome of review• Reduce risks of potential conflicts of interest• MCG psychotherapy case – not independent review
– Informed consent– Respect for potential and enrolled subjects
• Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701-2711– Social or scientific value– Scientific validity– Fair subject selection– Favorable risk-benefit ratio– Independent review– Informed consent
• Protection of vulnerable populations – children, incapacitated adults, prisoners, pregnant women, and others
• Must consider possibility of coerced consent via inducements or vulnerability– Willowbrook
• What needs to ne disclosed? Possible financial gain for researchers?– Respect for potential and enrolled subjects
• Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701-2711– Social or scientific value– Scientific validity– Fair subject selection– Favorable risk-benefit ratio– Independent review– Informed consent– Respect for potential and enrolled subjects
• Privacy and confidentiality• Non-identification of subjects
Scientific misconduct (fraud)
• Falsification or fabrication of data• Newton, Mendel, Millikan• Scott S. Reuben faked data in 21 studies on pain medicines• Andrew Wakefield and relationship between vaccines and autism• Woo-Suk Hwang and cloning of human embryonic stem cells• Dipak Das U Conn resveratrol 26 articles retracted• Anil Potti, Duke, individualized treatments for ovarian cancer
– 1/3 of 40 papers retracted, another 1/3 portions retracted• Marc D. Hauser Harvard evolutionary biologist fabricated and falsified data• Eric Poehlman obesity research imprisoned
• Scientific recordkeeping– Importance of lab books in verifying collection of data
Resources
• Medapps.mercer.edu• http://www.wame.org/ethics-resources/we
b-resources-on-publication-and-research-ethics/
• http://www.fic.nih.gov/ResearchTopics/Pages/Bioethics.aspx